drugset

drugset / Trial / NCT00309868

Study of Nesiritide in Diastolic Heart Failure.

NCT00309868 ↗

Phase 1/2 Completed 20 enrolled Massachusetts General Hospital Scios, Inc. · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

We hypothesize that nesiritide will have favorable effect in decreasing heart filling pressures and echocardiogram studies.

Timeline

Start: 2002-12
Primary completion: 2003-12
Completion: 2003-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Nesiritide	Protein / enzyme biologic	—	—

Indications